Targeting endothelial cells by gene therapy

Abstract

In this issue of Blood, Abel et al designed lentiviral vectors (LVs) enabling specific gene delivery into endothelial cells in vivo. This opens new perspectives for gene therapy of hereditary disorders, cardiovascular diseases, and cancer. 1 © 2013 by The American Society of Hematology.